Methods of treating fibrosing diseases by induction of immune tolerance

Details for Australian Patent Application No. 2006315428 (hide)

Owner The University of Tennessee Research Foundation

Inventors Postlethwaite, Arnold E.; Kang, Andrew H.

Agent Spruson & Ferguson

Pub. Number AU-B-2006315428

PCT Pub. Number WO2007/059211

Priority 60/737,194 16.11.05 US

Filing date 16 November 2006

Wipo publication date 24 May 2007

Acceptance publication date 1 December 2011

International Classifications

A61K 35/12 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution - Materials from mammals or birds

A61K 38/39 (2006.01) Medicinal preparations containing peptides - Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin (CIG)

Event Publications

22 May 2008 PCT application entered the National Phase

  PCT publication WO2007/059211 Priority application(s): WO2007/059211

1 December 2011 Application Accepted

  Published as AU-B-2006315428

29 March 2012 Standard Patent Sealed

19 April 2012 Licence Registered

  The University of Tennessee Research Foundation ( arGentis, LLC ) Mortgages Registered - Section 187, Reg. 19 (The name in the parentheses is that of the mortgagee)

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006315436-Azaindazoles useful as inhibitors of kinases

2006315425-Methods and apparatus for intraocular brachytherapy